DDLSS: Amy Berrington de Gonzalez "Is there an epidemic of early-onset cancers"

Berrington de González was on the faculty at the University of Oxford and then Johns Hopkins Bloomberg School of Public Health before moving to the Radiation Epidemiology Branch at the National Cancer Institute (NCI) in 2008. She was awarded NIH scientific tenure in 2012, and was promoted to Branch Chief in 2014. In 2022, she took up the position of Professor of Clinical Epidemiology at the in London, UK. Berrington de González serves on two radiation risk committees for the National Academy of Science and previously served on the UK Health Protection Agency's Advisory Group on Ionising Radiation, and the UK Breast Screening Programme's Advisory Group. She is currently Vice Chair of the NAS Nuclear and Radiation Studies Board and has participated in many national and international radiation committees. She served on the editorial board for the American Journal of Epidemiology. Berrington de González is co-PI of the UK Pediatric CT scans cohort, which was the first epidemiological study to suggest a direct link between CT scans and subsequent cancer risk. She also leads studies on the risk of second cancer after proton therapy and other emerging radiotherapy techniques. The overarching goal of Prof Berrington's research is to quantify the potential cancer risks from this important source of radiation exposure in order to provide information for public health and clinical purposes. Her interdisciplinary training in epidemiology and biostatistics allow her to pursue this goal using both theoretical risk projection modeling and also by conducting epidemiological studies of medically exposed populations. The studies vary across the dose-spectrum from low-dose diagnostic and screening procedures to high-dose radiotherapy, with distinct opportunities and challenges in each area.